{"transactions":[{"id":861776,"issuer":{"id":6679,"kind":"organization","name":"Nautilus Biotechnology, Inc."},"owners":[{"id":62836,"kind":"person","name":"Patel Sujal M","position":1,"cik":"0001378830","reported_name":"Patel Sujal M","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO, President, and Secretary"}}],"security":"Common Stock","published_at":"2026-03-04T23:37:20.000Z","date":"2026-03-04","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":2.6095,"value":65237.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average share price of an aggregate total of 25,000 shares purchased in the price range of $2.48 to $2.6095 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":10366721,"source":{"system":"sec-edgar","filing":"0001378830-26-000003","document":"wk-form4_1772667437.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808805/000137883026000003/wk-form4_1772667437.xml","form_type":"4"}},{"id":861773,"issuer":{"id":6679,"kind":"organization","name":"Nautilus Biotechnology, Inc."},"owners":[{"id":62836,"kind":"person","name":"Patel Sujal M","position":1,"cik":"0001378830","reported_name":"Patel Sujal M","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO, President, and Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-04T22:31:27.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":650000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to reporting person's continuous status as a \"Service Provider\" (as defined in the the Issuer's 2021 Equity Incentive Plan) through each vesting date, twenty-five percent (25%) of the shares subject to the Option shall vest on the one (1) year anniversary of the Vesting Commencement Date (as defined below), and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). The Vesting Commencement Date is January 1, 2026."}],"balance_after":650000,"derivative":{"exercise_price":2.32,"expiration_date":"2036-03-02","underlying":"Common Stock","underlying_shares":650000},"source":{"system":"sec-edgar","filing":"0001378830-26-000001","document":"wk-form4_1772663485.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808805/000137883026000001/wk-form4_1772663485.xml","form_type":"4"}},{"id":1044883,"issuer":{"id":6679,"kind":"organization","name":"Nautilus Biotechnology, Inc."},"owners":[{"id":62836,"kind":"person","name":"Patel Sujal M","position":1,"cik":"0001378830","reported_name":"Patel Sujal M","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO, President, and Secretary"}}],"security":"Common Stock","published_at":"2025-09-09T20:42:25.000Z","date":"2025-09-08","kind":"purchase","planned":false,"acquired":true,"shares":83500,"price":0.683,"value":57030.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 83,500 shares purchased in the price range of $0.6581 to $0.7145 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":10341721,"source":{"system":"sec-edgar","filing":"0001378830-25-000003","document":"wk-form4_1757450542.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808805/000137883025000003/wk-form4_1757450542.xml","form_type":"4"}},{"id":1044882,"issuer":{"id":6679,"kind":"organization","name":"Nautilus Biotechnology, Inc."},"owners":[{"id":62836,"kind":"person","name":"Patel Sujal M","position":1,"cik":"0001378830","reported_name":"Patel Sujal M","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO, President, and Secretary"}}],"security":"Common Stock","published_at":"2025-09-09T20:42:25.000Z","date":"2025-09-05","kind":"purchase","planned":false,"acquired":true,"shares":116500,"price":0.6742,"value":78544.3,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average share price of an aggregate total of 116,500 shares purchased in the price range of $0.6547 to $0.6899 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":10258221,"source":{"system":"sec-edgar","filing":"0001378830-25-000003","document":"wk-form4_1757450542.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808805/000137883025000003/wk-form4_1757450542.xml","form_type":"4"}},{"id":1194701,"issuer":{"id":6679,"kind":"organization","name":"Nautilus Biotechnology, Inc."},"owners":[{"id":62836,"kind":"person","name":"Patel Sujal M","position":1,"cik":"0001378830","reported_name":"Patel Sujal M","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO, President, and Secretary"}}],"security":"Common Stock","published_at":"2025-03-21T20:44:37.000Z","date":"2025-03-20","kind":"purchase","planned":false,"acquired":true,"shares":23933,"price":0.9982,"value":23889.9206,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 23,933 shares purchased in the price range of $0.9351 to $1.06 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":10141721,"source":{"system":"sec-edgar","filing":"0001808805-25-000034","document":"wk-form4_1742589871.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808805/000180880525000034/wk-form4_1742589871.xml","form_type":"4"}},{"id":1194700,"issuer":{"id":6679,"kind":"organization","name":"Nautilus Biotechnology, Inc."},"owners":[{"id":62836,"kind":"person","name":"Patel Sujal M","position":1,"cik":"0001378830","reported_name":"Patel Sujal M","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO, President, and Secretary"}}],"security":"Common Stock","published_at":"2025-03-21T20:44:37.000Z","date":"2025-03-19","kind":"purchase","planned":false,"acquired":true,"shares":53300,"price":0.9949,"value":53028.17,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average share price of an aggregate total of 53,300 shares purchased in the price range of $0.9469 to $1.10 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":10117788,"source":{"system":"sec-edgar","filing":"0001808805-25-000034","document":"wk-form4_1742589871.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808805/000180880525000034/wk-form4_1742589871.xml","form_type":"4"}},{"id":1229113,"issuer":{"id":6679,"kind":"organization","name":"Nautilus Biotechnology, Inc."},"owners":[{"id":62836,"kind":"person","name":"Patel Sujal M","position":1,"cik":"0001378830","reported_name":"Patel Sujal M","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO, President, and Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-04T21:51:39.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":650000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Option shall vest and become exercisable on the first anniversary of the Vesting Commencement Date, as defined below, and the balance of the shares subject to the Option shall vest and become exercisable on a ratable, monthly basis over the 36 months succeeding such first anniversary so long as the Reporting Person remains a Service Provider as provided in the Issuer's 2021 Equity Incentive Plan. Vesting Commencement Date shall mean January 1, 2025."}],"balance_after":650000,"derivative":{"exercise_price":1.24,"expiration_date":"2035-03-03","underlying":"Common Stock","underlying_shares":650000},"source":{"system":"sec-edgar","filing":"0001808805-25-000020","document":"wk-form4_1741125091.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808805/000180880525000020/wk-form4_1741125091.xml","form_type":"4"}},{"id":1584345,"issuer":{"id":6679,"kind":"organization","name":"Nautilus Biotechnology, Inc."},"owners":[{"id":62836,"kind":"person","name":"Patel Sujal M","position":1,"cik":"0001378830","reported_name":"Patel Sujal M","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO, President, and Secretary"}}],"security":"Common Stock","published_at":"2024-03-12T00:21:59.000Z","date":"2024-03-11","kind":"purchase","planned":false,"acquired":true,"shares":12044,"price":2.8409,"value":34215.7996,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 12,044 shares purchased in the price range of $2.75 to $3.00 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":10064488,"source":{"system":"sec-edgar","filing":"0001808805-24-000026","document":"wk-form4_1710202909.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808805/000180880524000026/wk-form4_1710202909.xml","form_type":"4"}},{"id":1584344,"issuer":{"id":6679,"kind":"organization","name":"Nautilus Biotechnology, Inc."},"owners":[{"id":62836,"kind":"person","name":"Patel Sujal M","position":1,"cik":"0001378830","reported_name":"Patel Sujal M","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO, President, and Secretary"}}],"security":"Common Stock","published_at":"2024-03-12T00:21:59.000Z","date":"2024-03-08","kind":"purchase","planned":false,"acquired":true,"shares":2430,"price":2.9885,"value":7262.055,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average share price of an aggregate total of 2,430  shares purchased in the price range of $2.96 to $3.00 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":10052444,"source":{"system":"sec-edgar","filing":"0001808805-24-000026","document":"wk-form4_1710202909.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808805/000180880524000026/wk-form4_1710202909.xml","form_type":"4"}},{"id":1589290,"issuer":{"id":6679,"kind":"organization","name":"Nautilus Biotechnology, Inc."},"owners":[{"id":62836,"kind":"person","name":"Patel Sujal M","position":1,"cik":"0001378830","reported_name":"Patel Sujal M","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO, President, and Secretary"}}],"security":"Common Stock","published_at":"2024-03-08T00:06:49.000Z","date":"2024-03-07","kind":"purchase","planned":false,"acquired":true,"shares":18854,"price":2.8866,"value":54423.9564,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average share price of an aggregate total of 18,854  shares purchased in the price range of $2.72 to $3.00 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":10050014,"source":{"system":"sec-edgar","filing":"0001628280-24-009754","document":"wk-form4_1709856399.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808805/000162828024009754/wk-form4_1709856399.xml","form_type":"4"}},{"id":1589289,"issuer":{"id":6679,"kind":"organization","name":"Nautilus Biotechnology, Inc."},"owners":[{"id":62836,"kind":"person","name":"Patel Sujal M","position":1,"cik":"0001378830","reported_name":"Patel Sujal M","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO, President, and Secretary"}}],"security":"Common Stock","published_at":"2024-03-08T00:06:49.000Z","date":"2024-03-06","kind":"purchase","planned":false,"acquired":true,"shares":9267,"price":2.7014,"value":25033.8738,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 9,267 shares purchased in the price range of $2.64 to $2.77 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":10031160,"source":{"system":"sec-edgar","filing":"0001628280-24-009754","document":"wk-form4_1709856399.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808805/000162828024009754/wk-form4_1709856399.xml","form_type":"4"}},{"id":1589288,"issuer":{"id":6679,"kind":"organization","name":"Nautilus Biotechnology, Inc."},"owners":[{"id":62836,"kind":"person","name":"Patel Sujal M","position":1,"cik":"0001378830","reported_name":"Patel Sujal M","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO, President, and Secretary"}}],"security":"Common Stock","published_at":"2024-03-08T00:06:49.000Z","date":"2024-03-05","kind":"purchase","planned":false,"acquired":true,"shares":7405,"price":2.6464,"value":19596.592,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average share price of an aggregate total of 7,405 shares purchased in the price range of $2.58 to $2.69 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":10021893,"source":{"system":"sec-edgar","filing":"0001628280-24-009754","document":"wk-form4_1709856399.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808805/000162828024009754/wk-form4_1709856399.xml","form_type":"4"}},{"id":1596999,"issuer":{"id":6679,"kind":"organization","name":"Nautilus Biotechnology, Inc."},"owners":[{"id":62836,"kind":"person","name":"Patel Sujal M","position":1,"cik":"0001378830","reported_name":"Patel Sujal M","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO, President, and Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-05T21:52:25.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":650000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to reporting person's continuous status as a \"Service Provider\" (as defined in the the Issuer's 2021 Equity Incentive Plan) through each vesting date, twenty-five percent (25%) of the shares subject to the Option shall vest on the one (1) year anniversary of the Vesting Commencement Date (as defined below), and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). The Vesting Commencement Date is January 1, 2024."}],"balance_after":650000,"derivative":{"exercise_price":2.72,"expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":650000},"source":{"system":"sec-edgar","filing":"0001808805-24-000024","document":"wk-form4_1709675514.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808805/000180880524000024/wk-form4_1709675514.xml","form_type":"4"}},{"id":1983913,"issuer":{"id":6679,"kind":"organization","name":"Nautilus Biotechnology, Inc."},"owners":[{"id":62836,"kind":"person","name":"Patel Sujal M","position":1,"cik":"0001378830","reported_name":"Patel Sujal M","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO, President, and Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-01T22:20:05.000Z","date":"2023-02-27","kind":"grant","acquired":true,"shares":650000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to reporting person's continuous status as a \"Service Provider\" (as defined in the the Issuer's 2021 Equity Incentive Plan) through each vesting date, twenty-five percent (25%) of the shares subject to the Option shall vest on the one (1) year anniversary of the Vesting Commencement Date (as defined below), and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). The Vesting Commencement Date is January 1, 2023."}],"balance_after":650000,"derivative":{"exercise_price":2,"expiration_date":"2033-02-27","underlying":"Common Stock","underlying_shares":650000},"source":{"system":"sec-edgar","filing":"0001808805-23-000032","document":"wf-form4_167770917669467.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808805/000180880523000032/wf-form4_167770917669467.xml","form_type":"4"}},{"id":2192022,"issuer":{"id":6679,"kind":"organization","name":"Nautilus Biotechnology, Inc."},"owners":[{"id":62836,"kind":"person","name":"Patel Sujal M","position":1,"cik":"0001378830","reported_name":"Patel Sujal M","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO, President, and Secretary"}}],"security":"Common Stock","published_at":"2022-08-08T23:48:58.000Z","date":"2022-08-08","kind":"purchase","acquired":true,"shares":8346,"price":2.9288,"value":24443.7648,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 8,346 shares purchased in the price range of $2.90 to $3.00 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":10014488,"source":{"system":"sec-edgar","filing":"0001808805-22-000089","document":"wf-form4_166000250690193.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808805/000180880522000089/wf-form4_166000250690193.xml","form_type":"4"}},{"id":2192021,"issuer":{"id":6679,"kind":"organization","name":"Nautilus Biotechnology, Inc."},"owners":[{"id":62836,"kind":"person","name":"Patel Sujal M","position":1,"cik":"0001378830","reported_name":"Patel Sujal M","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO, President, and Secretary"}}],"security":"Common Stock","published_at":"2022-08-08T23:48:58.000Z","date":"2022-08-05","kind":"purchase","acquired":true,"shares":41654,"price":2.9204,"value":121646.3416,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average share price of an aggregate total of 41,654 shares purchased in the price range of $2.76 to $3.00 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":10006142,"source":{"system":"sec-edgar","filing":"0001808805-22-000089","document":"wf-form4_166000250690193.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808805/000180880522000089/wf-form4_166000250690193.xml","form_type":"4"}},{"id":2276357,"issuer":{"id":6679,"kind":"organization","name":"Nautilus Biotechnology, Inc."},"owners":[{"id":62836,"kind":"person","name":"Patel Sujal M","position":1,"cik":"0001378830","reported_name":"Patel Sujal M","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO, President, and Secretary"}}],"security":"Common Stock","published_at":"2022-05-11T00:28:04.000Z","date":"2022-05-09","kind":"purchase","acquired":true,"shares":50000,"price":3.96,"value":198000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average share price of an aggregate total of 50,000 shares purchased in the price range of $3.8299 to $4.00 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":9964488,"source":{"system":"sec-edgar","filing":"0001808805-22-000054","document":"wf-form4_165222886775160.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808805/000180880522000054/wf-form4_165222886775160.xml","form_type":"4"}},{"id":2350586,"issuer":{"id":6679,"kind":"organization","name":"Nautilus Biotechnology, Inc."},"owners":[{"id":62836,"kind":"person","name":"Patel Sujal M","position":1,"cik":"0001378830","reported_name":"Patel Sujal M","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO, President, and Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-04T22:39:16.000Z","date":"2022-03-03","kind":"exercise","acquired":false,"shares":100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to reporting person's continuous status as a \"Service Provider\" (as defined in the Nautilus Subsidiary, Inc. 2017 Equity Incentive Plan) through each vesting date, twenty-five percent (25%) of the shares subject to the Option shall vest on the one (1) year anniversary of the Vesting Commencement Date (as defined below), and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). The Vesting Commencement date is January 31, 2021."}],"balance_after":788733,"derivative":{"exercise_price":10,"expiration_date":"2031-01-31","underlying":"Common Stock","underlying_shares":100},"source":{"system":"sec-edgar","filing":"0001808805-22-000026","document":"wf-form4_164643353372172.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1808805/000180880522000026/wf-form4_164643353372172.xml","form_type":"4"}},{"id":2350585,"issuer":{"id":6679,"kind":"organization","name":"Nautilus Biotechnology, Inc."},"owners":[{"id":62836,"kind":"person","name":"Patel Sujal M","position":1,"cik":"0001378830","reported_name":"Patel Sujal M","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO, President, and Secretary"}}],"security":"Common Stock","published_at":"2022-03-04T22:39:16.000Z","date":"2022-03-04","kind":"exercise","acquired":true,"shares":100,"price":10,"value":1000.0,"ownership":{"direct":true},"balance_after":9914488,"source":{"system":"sec-edgar","filing":"0001808805-22-000026","document":"wf-form4_164643353372172.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808805/000180880522000026/wf-form4_164643353372172.xml","form_type":"4"}},{"id":2350584,"issuer":{"id":6679,"kind":"organization","name":"Nautilus Biotechnology, Inc."},"owners":[{"id":62836,"kind":"person","name":"Patel Sujal M","position":1,"cik":"0001378830","reported_name":"Patel Sujal M","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO, President, and Secretary"}}],"security":"Common Stock","published_at":"2022-03-04T22:39:16.000Z","date":"2022-03-03","kind":"purchase","acquired":true,"shares":50000,"price":3.5978,"value":179890.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average share price of an aggregate total of 50,000 shares purchased in the price range of $3.57 to $3.60 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":9914388,"source":{"system":"sec-edgar","filing":"0001808805-22-000026","document":"wf-form4_164643353372172.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808805/000180880522000026/wf-form4_164643353372172.xml","form_type":"4"}},{"id":2372317,"issuer":{"id":6679,"kind":"organization","name":"Nautilus Biotechnology, Inc."},"owners":[{"id":62836,"kind":"person","name":"Patel Sujal M","position":1,"cik":"0001378830","reported_name":"Patel Sujal M","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO, President, and Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-26T01:09:36.000Z","date":"2022-02-25","kind":"grant","acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to reporting person's continuous status as a \"Service Provider\" (as defined in the the Issuer's 2021 Equity Incentive Plan) through each vesting date, twenty-five percent (25%) of the shares subject to the Option shall vest on the one (1) year anniversary of the Vesting Commencement Date (as defined below), and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month).  The Vesting Commencement Date is February 25, 2022."}],"balance_after":400000,"derivative":{"exercise_price":3.78,"expiration_date":"2032-02-25","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001808805-22-000023","document":"wf-form4_164583775921533.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808805/000180880522000023/wf-form4_164583775921533.xml","form_type":"4"}},{"id":2488935,"issuer":{"id":6679,"kind":"organization","name":"Nautilus Biotechnology, Inc."},"owners":[{"id":62836,"kind":"person","name":"Patel Sujal M","position":1,"cik":"0001378830","reported_name":"Patel Sujal M","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO, President, and Secretary"}}],"security":"Common Stock","published_at":"2021-12-02T13:49:57.000Z","date":"2021-12-01","kind":"purchase","acquired":true,"shares":88022,"price":4.7306,"value":416396.8732,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 88,022 shares purchased in the price range of $4.44 to $5.00 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":9864388,"source":{"system":"sec-edgar","filing":"0001808805-21-000027","document":"wf-form4_163845298373636.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808805/000180880521000027/wf-form4_163845298373636.xml","form_type":"4"}},{"id":2488934,"issuer":{"id":6679,"kind":"organization","name":"Nautilus Biotechnology, Inc."},"owners":[{"id":62836,"kind":"person","name":"Patel Sujal M","position":1,"cik":"0001378830","reported_name":"Patel Sujal M","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO, President, and Secretary"}}],"security":"Common Stock","published_at":"2021-12-02T13:49:57.000Z","date":"2021-11-30","kind":"purchase","acquired":true,"shares":161978,"price":4.7215,"value":764779.127,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average share price of an aggregate total of 161,978 shares purchased in the price range of $4.48 to $4.85 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":9776366,"source":{"system":"sec-edgar","filing":"0001808805-21-000027","document":"wf-form4_163845298373636.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808805/000180880521000027/wf-form4_163845298373636.xml","form_type":"4"}}]}